Yüklüyor......
Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
Statins lower low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hsCRP), and the addition of ezetimibe to statins further reduces LDL-C and hsCRP. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a potentially important pathogenic factor participating in the pro...
Kaydedildi:
| Yayımlandı: | Exp Ther Med |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5704334/ https://ncbi.nlm.nih.gov/pubmed/29201198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5175 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|